Advertisement
Advertisement

MNPR

MNPR logo

Monopar Therapeutics Inc. Common Stock

119.21
USD
Sponsored
-1.00
-0.83%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

119.03

-0.17
-0.15%

Monopar Therapeutics Inc. Common Stock Profile

About

Monopar Therapeutics Inc. is a biopharmaceutical company. It is focused on developing drugs for cancer patients. The company's intellectual property pipeline consists of Validive(R), Camsirubicin (MNPR-201) and MNPR-101 which are in clinical stage. Monopar Therapeutics Inc. is based in Wilmette, United States.

Info & Links

CEO

Chandler D. Robinson

Headquarters

1000 SKOKIE BLVD SUITE 350
WILMETTE, IL 60091, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.monopartx.com

Auditor

BPM LLP

Share holders

--

Employees

22

Monopar Therapeutics Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

797.42M

Enterprise Value

744.88M

Enterprise Value/EBITDA(ttm)

-38.18

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

5.90

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-12.84%

Return on Invested Capital(ttm)

-13.78%

Return on Assets(ttm)

-12.57%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-19.51M

Net Income Available to Common(ttm)

-14.98M

Diluted EPS(ttm)

-1.90

Share Statistics

Beta (5Y Monthly)

1.47

52-Week Change

197.28%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

6.70M

Dividend Yield

0.00%

Float4

6.05M

% Held by Insiders

9.70%

% Held by Institutions

1.83%

Balance Sheet

Total Cash(mrq)

137.49M

Total Cash Per Share(mrq)

20.52

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

56.04%

Quick Ratio(mrq)

56.04%

Book Value Per Share(mrq)

20.21

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.41

Free Cash Flow(ytd)

-3.47M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement